- Home
- CMPX vs AMRN Comparison
CMPX vs AMRN Comparison
Compare CMPX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- AMRN
- Stock Information
- Founded
- CMPX 2014
- AMRN 1989
- Country
- CMPX United States
- AMRN Ireland
- Employees
- CMPX N/A
- AMRN N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- CMPX Health Care
- AMRN Health Care
- Exchange
- CMPX Nasdaq
- AMRN Nasdaq
- Market Cap
- CMPX 229.5M
- AMRN 189.2M
- IPO Year
- CMPX N/A
- AMRN 1993
- Fundamental
- Price
- CMPX $1.75
- AMRN $9.11
- Analyst Decision
- CMPX Strong Buy
- AMRN Sell
- Analyst Count
- CMPX 8
- AMRN 2
- Target Price
- CMPX $13.38
- AMRN $7.00
- AVG Volume (30 Days)
- CMPX 2.8M
- AMRN 103.6K
- Earning Date
- CMPX 05-12-2025
- AMRN 04-30-2025
- Dividend Yield
- CMPX N/A
- AMRN N/A
- EPS Growth
- CMPX N/A
- AMRN N/A
- EPS
- CMPX N/A
- AMRN N/A
- Revenue
- CMPX $850,000.00
- AMRN $228,614,000.00
- Revenue This Year
- CMPX $47.65
- AMRN N/A
- Revenue Next Year
- CMPX $2,767.57
- AMRN $5.18
- P/E Ratio
- CMPX N/A
- AMRN N/A
- Revenue Growth
- CMPX N/A
- AMRN N/A
- 52 Week Low
- CMPX $0.77
- AMRN $7.00
- 52 Week High
- CMPX $4.08
- AMRN $20.60
- Technical
- Relative Strength Index (RSI)
- CMPX 41.42
- AMRN 48.45
- Support Level
- CMPX $1.60
- AMRN $8.32
- Resistance Level
- CMPX $1.78
- AMRN $10.06
- Average True Range (ATR)
- CMPX 0.27
- AMRN 0.87
- MACD
- CMPX 0.03
- AMRN 0.15
- Stochastic Oscillator
- CMPX 38.01
- AMRN 60.40
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.